Literature DB >> 9123834

Propagation of the human polyomavirus, JCV, in human neuroblastoma cell lines.

T Shinohara1, K Nagashima, E O Major.   

Abstract

Susceptibility to infection by the human polyomavirus, JCV, is determined by intracellular mechanisms which control transcription and replication. Originally thought to propagate well only in human cells of oligodendroglial lineage, JCV has recently been shown to infect astrocytes, astrogliomas, and a neuroblastoma cell line. The data reported here describe two cell types that have been subcultured from a human neuroblastoma cell line, SK-N-SH. The SH-SY5Y subclone displays neuronal phenotypes and is not susceptible to JCV infection, while the SH-EP subclone displays glial cell phenotypes and is susceptible to infection. Binding of nuclear proteins from the permissive SH-EP cells to the nuclear factor-1 (NF-1) site in the JCV regulatory DNA sequences results in a gel shift pattern that is different from the nonpermissive SH-SY5Y cell proteins. Northern analysis of mRNA for the four classes of NF-1 proteins showed a predominance of the NF-1/X class in SH-EP cells similar to the highly permissive human fetal glial cells. Very low levels of mRNA for NF-1/X were seen in the nonpermissive SH-SY5Y cells, similar to that seen for the nonpermissive HeLa cells. Several other cell lines tested that were permissive for JCV infection also showed synthesis of the NF-1/X class of proteins. SH-EP cells represent a cell line in a glial cell lineage which is susceptible to JCV multiplication. These cells may be a useful cell culture system for the investigation of DNA binding factors which correlates with viral susceptibility.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9123834     DOI: 10.1006/viro.1996.8409

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

Review 1.  A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region.

Authors:  P N Jensen; E O Major
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

2.  Analysis of capsid formation of human polyomavirus JC (Tokyo-1 strain) by a eukaryotic expression system: splicing of late RNAs, translation and nuclear transport of major capsid protein VP1, and capsid assembly.

Authors:  Y Shishido-Hara; Y Hara; T Larson; K Yasui; K Nagashima; G L Stoner
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  JC virus multiplication in human hematopoietic progenitor cells requires the NF-1 class D transcription factor.

Authors:  M C Monaco; B F Sabath; L C Durham; E O Major
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  Interactions between c-Jun, nuclear factor 1, and JC virus promoter sequences: implications for viral tropism.

Authors:  Veerasamy Ravichandran; Bruce F Sabath; Peter N Jensen; Sidney A Houff; Eugene O Major
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

Review 5.  Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy.

Authors:  Leslie J Marshall; Eugene O Major
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-17       Impact factor: 4.147

6.  Differentiated Human SH-SY5Y Cells Provide a Reductionist Model of Herpes Simplex Virus 1 Neurotropism.

Authors:  Mackenzie M Shipley; Colleen A Mangold; Chad V Kuny; Moriah L Szpara
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

7.  JC virus-induced changes in cellular gene expression in primary human astrocytes.

Authors:  Sujatha Radhakrishnan; Jessica Otte; Sahnila Enam; Luis Del Valle; Kamel Khalili; Jennifer Gordon
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Rearrangement patterns of JC virus noncoding control region from different biological samples.

Authors:  V Pietropaolo; M Videtta; D Fioriti; M Mischitelli; A Arancio; N Orsi; A M Degener
Journal:  J Neurovirol       Date:  2003-12       Impact factor: 2.643

9.  Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment.

Authors:  Valeria Pietropaolo; Anna Bellizzi; Elena Anzivino; Marco Iannetta; Maria Antonella Zingaropoli; Donatella Maria Rodio; Manuela Morreale; Simona Pontecorvo; Ada Francia; Vincenzo Vullo; Anna Teresa Palamara; Maria Rosa Ciardi
Journal:  J Neurovirol       Date:  2015-05-01       Impact factor: 2.643

Review 10.  New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy.

Authors:  Anna Bellizzi; Elena Anzivino; Donatella Maria Rodio; Anna Teresa Palamara; Lucia Nencioni; Valeria Pietropaolo
Journal:  Clin Dev Immunol       Date:  2013-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.